Signature Pharmaceuticals Ltd.

For the use of only a Registered Medical Practitioner or a Hospital or a Laboratory


Orligal (orlistat) is a gastrointestinal lipase inhibitor for obesity management that acts by inhibiting the absorption of dietary fats. Orlistat is (S)-2-formylamino-4-methyl-pentanoic acid (S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl] methyl]-dodecyl ester. Its empirical formula is C29H53NO5, and its molecular weight is 495.7. It is a single diastereomeric molecule that contains four chiral centers, with a negative optical rotation in ethanol at 529 nm.

The structure is: Orlistat is a white to off-white crystalline powder. Orlistat is practically insoluble in water, freely soluble in chloroform, and very soluble in methanol and ethanol. Orlistat has no pK within the physiological pH range.

USES: Orligal is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. Orligal is also indicated to reduce the risk for weight regain after prior weight loss. Orligal is indicated for obese patients with an initial body mass index (BMI) ≥ 30 kg/m² or ≥ 27 kg/m² in the presence of other risk factors (e.g., hypertension, diabetes, dyslipidemia).

Orlistat 120 mg
84 capsules (4×21 caps) 120mg Orlistat / caps


Testosterone Undecanoate 40 mg Capsule is a naturally occurring sex hormone in men and women. This medicine is used to treat conditions caused by low levels of testosterone hormone in the body. These conditions include delayed puberty, impotence, and other hormonal imbalances.

Hypogonadism: This medicine is used to treat hypogonadism, a condition in which the body does not produce enough testosterone due to decreased functioning of male sex organs.
Breast cancer: This medicine is used to treat breast cancer by stopping the release of estrogen.

Testosterone Undecanoate 40 mg
60 softgel capsules (6×10 caps) 40mg Testosterone Undecanoate / caps
About Us

Our age management research helps to improve quality of life of men everywhere; rejecting the standard that ageing requires a person to reduce activity and lessen the enjoyment of life.


Response time is 2-3 business days, depending on the nature of the question.